Flash e-reader

 Go to e-reader chapter








Table 6.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 2000 to 2009

Recipients with Pancreas Transplant Alone (PTA) Transplants

  Year of Transplant
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Functioning Graft at Discharge 113 151 168 141 170 181 153 188 202 164
With Immunosuppression Info 113 150 168 139 169 181 152 186 201 161
Corticosteroids Any in Category 78.8% 77.3% 69.0% 53.2% 49.7% 51.9% 52.0% 58.1% 56.7% 44.1%
Steroids 78.8% 77.3% 69.0% 53.2% 49.7% 51.9% 52.0% 58.1% 56.7% 44.1%
Cyclosporine Any in Category 4.4% 4.0% 3.6% 2.2% 1.2% 0.0% 2.0% 2.2% 1.5% 1.2%
Sandimmmune 0.0% 1.3% 0.0% 0.0% 0.0% 0.0% 0.7% 0.5% 0.0% 0.0%
Neoral 4.4% 2.7% 3.6% 2.2% 1.2% 0.0% 1.3% 1.6% 1.5% 1.2%
Tacrolimus Any in Category 92.9% 94.7% 95.2% 82.7% 75.7% 92.3% 94.7% 95.7% 97.5% 97.5%
Tacrolimus 92.9% 94.7% 95.2% 82.7% 75.7% 92.3% 94.7% 95.2% 97.5% 97.5%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.5% 0.0% 0.0%
Antimetabolites Any in Category 69.0% 62.0% 59.5% 59.7% 60.4% 57.5% 53.9% 59.1% 62.2% 65.2%
Mycophenolate Mofetil 67.3% 60.7% 57.7% 59.7% 59.2% 54.7% 50.0% 51.6% 55.2% 59.6%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 2.8% 3.9% 5.9% 6.5% 5.6%
Azathioprine 1.8% 1.3% 1.8% 0.0% 1.2% 0.0% 0.0% 1.6% 0.5% 0.0%
mTOR Inhibitors Any in Category 8.0% 9.3% 15.5% 17.3% 11.2% 14.9% 25.7% 17.2% 10.9% 14.3%
Sirolimus 8.0% 9.3% 15.5% 17.3% 11.2% 14.9% 25.7% 17.2% 10.9% 14.3%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of October 1, 2010.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.